You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pexa-Vec

Showing 1 - 25 of 43
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Colorectal Cancer, Colorectal Carcinoma, Colorectal Adenocarcinoma Trial run by the NCI (Durvalumab, Tremelimumab, Pexa-Vec)

Active, not recruiting
Has Results
  • Colorectal Cancer
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 24, 2023

Metastatic Tumor, Advanced Tumor Trial in France (Pexa-Vec, Ipilimumab)

Completed
  • Metastatic Tumor
  • Advanced Tumor
  • Bordeaux, France
  • +4 more
Jul 22, 2022

Local Progression or Metastatic Melanoma With Failed First-line Treatment Trial in Beijing (Pexa-Vec combined with ZKAB001,

Recruiting
  • Local Progression or Metastatic Melanoma With Failed First-line Treatment
  • Pexa-Vec combined with ZKAB001
  • ZKAB001 monotherapy
  • Beijing, China
    Beijing Cancer Hospital
Mar 30, 2022

Hepatocellular Carcinoma (HCC) Trial in Nancy, Paris (Pexastimogene Devacirepvec (Pexa Vec), Nivolumab)

Terminated
Has Results
  • Hepatocellular Carcinoma (HCC)
  • Nancy, France
  • +1 more
Oct 21, 2021

Solid Tumors, Soft-tissue Sarcoma, Breast Cancer Trial in Bordeaux (Cyclophosphamide and JX-594 dose escalation,

Recruiting
  • Solid Tumors
  • +2 more
  • Cyclophosphamide and JX-594 dose escalation
  • +3 more
  • Bordeaux, France
    Institut Bergonie
Feb 1, 2022

Renal Cell Carcinoma Trial in Australia, Korea, Republic of, United States (Pexastimogene Devacirepvec (Pexa-Vec), Cemiplimab)

Active, not recruiting
  • Renal Cell Carcinoma
  • Pexastimogene Devacirepvec (Pexa-Vec)
  • Cemiplimab
  • Irvine, California
  • +17 more
Oct 26, 2022

Hepatocellular Carcinoma (HCC) Trial in Worldwide (Pexastimogene Devacirepvec (Pexa Vec), Sorafenib)

Completed
Has Results
  • Hepatocellular Carcinoma (HCC)
  • Birmingham, Alabama
  • +141 more
Dec 11, 2020

Hepatocellular Carinoma Trial in Korea, Republic of, Spain, United States (JX-594 recombinant vaccina GM-CSF)

Completed
Has Results
  • Hepatocellular Carinoma
  • JX-594 recombinant vaccina GM-CSF
  • Scottsdale, Arizona
  • +4 more
Dec 29, 2020

Colorectal Carcinoma, CRC Trial in Canada, France, United States (JX-594, Irinotecan)

Completed
Has Results
  • Colorectal Carcinoma
  • CRC
  • Scottsdale, Arizona
  • +10 more
Dec 11, 2020

Sarcoma, Epithelioid Sarcoma, Cutaneous Angiosarcoma Trial in Stanford, New York (Talimogene Laherparepvec (T-VEC),

Recruiting
  • Sarcoma
  • +2 more
  • Stanford, California
  • +1 more
Feb 2, 2023

Melanoma Stage III, Melanoma Stage IV Trial in Amsterdam (T-VEC)

Recruiting
  • Melanoma Stage III
  • Melanoma Stage IV
  • Amsterdam, NH, Netherlands
    Antoni van Leeuwenhoek ziekenhuis
Feb 11, 2022

Dystrophic Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa, Dominant Dystrophic Epidermolysis Bullosa Trial in

Completed
  • Dystrophic Epidermolysis Bullosa
  • +2 more
  • Topical Beremagene Geperpavec
  • Placebo
  • Rancho Santa Margarita, California
  • +2 more
Aug 1, 2022

Angiosarcoma of Skin Trial in Tampa (T-VEC)

Active, not recruiting
  • Angiosarcoma of Skin
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Mar 22, 2022

Non-melanoma Skin Cancer, Basal Cell Carcinoma, Squamous Cell Carcinoma Trial in Zurich (Talimogene Laherparepvec (T-VEC))

Completed
  • Non-melanoma Skin Cancer
  • +4 more
  • Talimogene Laherparepvec (T-VEC)
  • Zurich, Switzerland
    Department of Dermatology, University Hospital Zurich
Mar 17, 2022

Melanoma, Merkel Cell Carcinoma, Other Solid Tumors Trial in Middletown, Harrison, New York (TALIMOGENE LAHERPAREPVEC (TVEC),

Active, not recruiting
  • Melanoma
  • +2 more
  • TALIMOGENE LAHERPAREPVEC (TVEC)
  • Hypofractionated Radiotherapy
  • Middletown, New Jersey
  • +2 more
Jul 13, 2022

Breast Cancer Trial in Barcelona, Madrid, Valencia (Talimogene laherparepvec, Atezolizumab)

Active, not recruiting
  • Breast Cancer
  • Barcelona, Spain
  • +3 more
Sep 27, 2022

Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer, Fallopian Tube Cancer Trial in Orlando, Albuquerque

Recruiting
  • Platinum-resistant Ovarian Cancer
  • +6 more
  • olvimulogene nanivacirepvec
  • +3 more
  • Orlando, Florida
    AdventHealth Cancer Institute
Sep 1, 2022

Melanoma and Sarcoma Trial in London (Talimogene laherparepvec (T-VEC))

Completed
  • Melanoma and Sarcoma
  • Talimogene laherparepvec (T-VEC)
  • London, United Kingdom
    The Royal Marsden NHS Foundation Trust
Aug 17, 2021

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

Recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +13 more
  • San Francisco, California
    University of California, San Francisco
Jan 6, 2023

Wounds in Patients With Dystrophic Epidermolysis Bullosa (DEB)

Withdrawn
  • Dystrophic Epidermolysis Bullosa
  • DEB - Dystrophic Epidermolysis Bullosa
    • Redwood City, California
      Stanford University
    Sep 10, 2021

    Dystrophic Epidermolysis Bullosa, DEB - Dystrophic Epidermolysis Bullosa, Recessive Dystrophic Epidermolysis Bullosa Trial in

    Recruiting
    • Dystrophic Epidermolysis Bullosa
    • +3 more
    • Open Label Topical Beremagene Geperpavec (B-VEC)
    • Rancho Santa Margarita, California
    • +5 more
    Jun 7, 2021

    Unresectable Stage IIIB-IV Malignant Melanoma Trial in Japan (Talimogene laherparepvec)

    Completed
    Has Results
    • Unresectable Stage IIIB-IV Malignant Melanoma
    • Talimogene laherparepvec
    • Nagoya-shi, Aichi, Japan
    • +8 more
    Jan 13, 2023

    Molecular Phenotyping of Post-COVID With Focus on Lung

    Recruiting
    • Long COVID
      • Stockholm, Sverige, Sweden
        Karolinska Institutet/Karolinska University Hospital Solna
      Jun 7, 2023

      Childhood Ependymoma Trial in Worldwide (16 weeks of VEC + CDDP, VEC + HD-MTX, Chemotherapy + Valproate)

      Recruiting
      • Childhood Ependymoma
      • 16 weeks of VEC + CDDP
      • +6 more
      • Graz, Austria
      • +39 more
      Oct 6, 2021

      Exhaled Breath Particles in Lung Cancer

      Recruiting
      • Lung Cancer
      • +3 more
      • EBPcollected using the PExA device.
      • Lund, Skåne Län, Sweden
        Skåne University Hospital
      May 24, 2022